Skip to main content
Top
Published in: Acta Neuropathologica 5/2003

01-11-2003 | Regular Paper

Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue

Authors: Ulrich J. Knappe, Christian Hagel, Björn W. Lisboa, Waldemar Wilczak, Dieter K. Lüdecke, Wolfgang Saeger

Published in: Acta Neuropathologica | Issue 5/2003

Login to get access

Abstract

Data on the dural invasiveness of pituitary adenomas have been correlated to the expression of matrix metalloproteinases (e.g. MMP-9). Serine proteases have not yet been investigated in human pituitary adenomas. In this study, paraffin-embedded material from 84 human pituitary adenomas (acromegaly n=18, Cushing's disease n=21, prolactinoma n=18, thyroid-stimulating hormone-secreting adenoma n=1, nonsecreting adenoma n=26) and 9 nontumourous anterior pituitary lobes (obtained from patients with prostate cancer) was immunohistochemically analysed for expression of MMP-2, MMP-9, tissue inhibitor of metalloproteinases-2 (TIMP-2), urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), tissue-type plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), and interleukin-6 (IL-6). Cavernous sinus invasion was determined by assessment of preoperative magnetic resonance imaging and intraoperative inspection (invasive n=50, noninvasive n=34). In pituitary adenomas, reactions were positive (diffuse expression) to MMP-2 (74% of cases), MMP-9 (49%), TIMP-2 (88%), uPA (89%), uPAR (90%), tPA (69%), and PAI-1 (87%). A weak expression of IL-6 was found in 12% of the adenomas. All reactions were positive (focal expression) in every sample of anterior lobe tissue, except for uPA (negative in 3 out of 9 cases), and IL-6 (faintly positive in 5 out of 8 cases). Adenomas showed remarkably greater expression of uPA than anterior lobe tissue (Chi-square P<0.05). Nonsecreting adenomas exhibited a stronger tendency towards overexpression of uPA in invasive tumours when compared to noninvasive adenomas (Chi-square P=0.053). We found no correlation of MMP-9 expression and tumour invasion. TIMP-2 was overexpressed in noninvasive as compared to invasive adenomas (Chi-square P<0.05). The interrelationship between MMPs and serine proteinases in pituitary adenomas remains to be elucidated. From our data, a correlation between IL-6 and an activation of MMP-9 cannot be proven. The uPA-system may, however, play a role in dural invasion of pituitary adenomas.
Literature
1.
go back to reference Abe T, Lüdecke DK (2001) Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre. Eur J Endocrinol 145:137–145PubMed Abe T, Lüdecke DK (2001) Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre. Eur J Endocrinol 145:137–145PubMed
2.
go back to reference Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1–22PubMed Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1–22PubMed
3.
go back to reference Beaulieu E, Kachra Z, Mousseau N, Delbecchi L, Hardy J, Béliveau R (1999) Matrix metalloproteinases and their inhibitors in human pituitary tumors. Neurosurgery 45:1432–1441PubMed Beaulieu E, Kachra Z, Mousseau N, Delbecchi L, Hardy J, Béliveau R (1999) Matrix metalloproteinases and their inhibitors in human pituitary tumors. Neurosurgery 45:1432–1441PubMed
4.
go back to reference Behncken A, Saeger W (1991) Lectin bindings in pituitary adenomas and normal pituitaries. Pathol Res Pract 187:629–631PubMed Behncken A, Saeger W (1991) Lectin bindings in pituitary adenomas and normal pituitaries. Pathol Res Pract 187:629–631PubMed
5.
go back to reference Bindal AK, Hammoud M, Shi WM, Wu SZ, Sawaya R, Rao JS (1994) Prognostic significance of proteolytic enzymes in human brain tumors. J Neurooncol 22:101–110PubMed Bindal AK, Hammoud M, Shi WM, Wu SZ, Sawaya R, Rao JS (1994) Prognostic significance of proteolytic enzymes in human brain tumors. J Neurooncol 22:101–110PubMed
6.
go back to reference Duffy MJ (1996) Proteases as prognostic markers in cancer. Clin Cancer Res 2:613–618PubMed Duffy MJ (1996) Proteases as prognostic markers in cancer. Clin Cancer Res 2:613–618PubMed
7.
go back to reference Foekens JA, Peters HA, Look MP, Portengen H, Schmitt M, Kramer MD, Brunner N, Jänicke F, Meijer-van Gelder ME, Henzen-Logmans SC, Putten WL van, Klijn JG (2000) The urokinase system of plasminogen activation and prognosis in 2,780 breast cancer patients. Cancer Res 60:636–643PubMed Foekens JA, Peters HA, Look MP, Portengen H, Schmitt M, Kramer MD, Brunner N, Jänicke F, Meijer-van Gelder ME, Henzen-Logmans SC, Putten WL van, Klijn JG (2000) The urokinase system of plasminogen activation and prognosis in 2,780 breast cancer patients. Cancer Res 60:636–643PubMed
8.
go back to reference Giese A, Westphal M (1996) Glioma invasion in the central nervous system. Neurosurgery 39:235–253PubMed Giese A, Westphal M (1996) Glioma invasion in the central nervous system. Neurosurgery 39:235–253PubMed
9.
go back to reference Gladson CL, Pijuan-Thompson V, Olman MA, Gillespie GY, Yacoub IZ (1995) Up-regulation of urokinase receptor genes in malignant astrocytoma. Am J Pathol 146:1150–1160PubMed Gladson CL, Pijuan-Thompson V, Olman MA, Gillespie GY, Yacoub IZ (1995) Up-regulation of urokinase receptor genes in malignant astrocytoma. Am J Pathol 146:1150–1160PubMed
10.
go back to reference Inuzuka K, Ogata Y, Nagase H, Shirouzu K (2000) Significance of coexpression of urokinase-type plasminogen activator and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma. J Surg Res 93:211–218CrossRefPubMed Inuzuka K, Ogata Y, Nagase H, Shirouzu K (2000) Significance of coexpression of urokinase-type plasminogen activator and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma. J Surg Res 93:211–218CrossRefPubMed
11.
go back to reference Jänicke F, Schmitt M, Pache L, Ulm K, Harbeck N, Hofler H (1993) Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat 24:195–208PubMed Jänicke F, Schmitt M, Pache L, Ulm K, Harbeck N, Hofler H (1993) Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat 24:195–208PubMed
12.
go back to reference Jones TH, Daniels M, James RA, Justice SK, McCorkle R, Price A, Kendall-Taylor P, Weetman AP (1994) Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas. J Clin Endocrinol Metab 78:180–187PubMed Jones TH, Daniels M, James RA, Justice SK, McCorkle R, Price A, Kendall-Taylor P, Weetman AP (1994) Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas. J Clin Endocrinol Metab 78:180–187PubMed
13.
go back to reference Kawamoto H, Uozumi T, Kawamoto K, Arita K, Yano Y, Hirohata T (1996) Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas. Acta Neurochir (Wien) 138:390–395 Kawamoto H, Uozumi T, Kawamoto K, Arita K, Yano Y, Hirohata T (1996) Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas. Acta Neurochir (Wien) 138:390–395
14.
go back to reference Kawamoto H, Kawamoto K, MizoueT, Uozumi T, Arita K, Kurisu K (1996) Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis. Acta Neurochir (Wien) 138:1442–1448 Kawamoto H, Kawamoto K, MizoueT, Uozumi T, Arita K, Kurisu K (1996) Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis. Acta Neurochir (Wien) 138:1442–1448
15.
go back to reference Knappe UJ, Lüdecke DK (1996) Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing's disease. Acta Neurochir (Wien) 65 (Suppl):31–34 Knappe UJ, Lüdecke DK (1996) Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing's disease. Acta Neurochir (Wien) 65 (Suppl):31–34
16.
go back to reference Lüdecke DK, Flitsch J, Knappe UJ, Saeger W (2001) Cushing's disease: a surgical view. J Neurooncol 54:151–166PubMed Lüdecke DK, Flitsch J, Knappe UJ, Saeger W (2001) Cushing's disease: a surgical view. J Neurooncol 54:151–166PubMed
17.
go back to reference Pàez-Pereda M, Goldberg V, Chervin A, Carrizo G, Molina A, Andrada J, Sauer J, Renner U, Stalla GK, Arzt E (1996) Interleukin-2 (IL-2) and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants. Mol Cell Endocrinol 124:33–42CrossRefPubMed Pàez-Pereda M, Goldberg V, Chervin A, Carrizo G, Molina A, Andrada J, Sauer J, Renner U, Stalla GK, Arzt E (1996) Interleukin-2 (IL-2) and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants. Mol Cell Endocrinol 124:33–42CrossRefPubMed
18.
go back to reference Pepper MS, Montesano R (1990) Proteolytic balance and capillary morphogenesis. Cell Differ Dev 32:319–328CrossRefPubMed Pepper MS, Montesano R (1990) Proteolytic balance and capillary morphogenesis. Cell Differ Dev 32:319–328CrossRefPubMed
19.
go back to reference Saeger W, Schröder S, Klöppel G (2001) Pathologie wichtiger Erkrankungen endokriner Organe (Schilddrüse ausgenommen). Pathologe 22:296–309CrossRefPubMed Saeger W, Schröder S, Klöppel G (2001) Pathologie wichtiger Erkrankungen endokriner Organe (Schilddrüse ausgenommen). Pathologe 22:296–309CrossRefPubMed
20.
go back to reference Selman WR, Laws ER Jr, Scheithauer BW, Carpenter SM (1986) The occurrence of dural invasion in pituitary adenomas. J Neurosurg 64:402–407PubMed Selman WR, Laws ER Jr, Scheithauer BW, Carpenter SM (1986) The occurrence of dural invasion in pituitary adenomas. J Neurosurg 64:402–407PubMed
21.
go back to reference Solcia E, Klöppel G, Sobin LH, Capella C, Lells RA de, Heitz PU, Horvath E, Kovacs K, Lack EE, Lloyd RJ, Rosai J, Scheithauer BW (2000) Histological typing of endocrine tumors, 2nd edn. Springer, Berlin Heidelberg New York, pp 1–149 Solcia E, Klöppel G, Sobin LH, Capella C, Lells RA de, Heitz PU, Horvath E, Kovacs K, Lack EE, Lloyd RJ, Rosai J, Scheithauer BW (2000) Histological typing of endocrine tumors, 2nd edn. Springer, Berlin Heidelberg New York, pp 1–149
22.
go back to reference Tomita T (1997) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in pituitary adenomas: possible markers of neuroendocrine cells. Endocr Pathol 8:305–313PubMed Tomita T (1997) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in pituitary adenomas: possible markers of neuroendocrine cells. Endocr Pathol 8:305–313PubMed
23.
go back to reference Tsagarakis S, Kontogeorgos G, Giannou P, Thalassinos N, Woolley J, Besser GM, Grossman A (1992) Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study. Clin Endocrinol (Oxf) 37:163–167 Tsagarakis S, Kontogeorgos G, Giannou P, Thalassinos N, Woolley J, Besser GM, Grossman A (1992) Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study. Clin Endocrinol (Oxf) 37:163–167
24.
go back to reference Turner HE, Nagy Z, Esiri MM, Harris AL, Wass JAH (2000) Role of matrix metalloproteinase 9 in pituitary tumor behaviour. J Clin Endocrinol Metab 85:2931–2935PubMed Turner HE, Nagy Z, Esiri MM, Harris AL, Wass JAH (2000) Role of matrix metalloproteinase 9 in pituitary tumor behaviour. J Clin Endocrinol Metab 85:2931–2935PubMed
25.
go back to reference Weidle UH, Wöllisch E, Ronne E, Ploug M, Behrendt N, Vries TJ de, Quax PH, Verheijen JH, Muijen GNP van, Ruiter DJ, Hoyer-Hansen G, Dano K (1994) Studies on functional and structural role of urokinase receptor and other components of the plasminogen activation system in malignancy. Ann Biol Clin 52:775–782 Weidle UH, Wöllisch E, Ronne E, Ploug M, Behrendt N, Vries TJ de, Quax PH, Verheijen JH, Muijen GNP van, Ruiter DJ, Hoyer-Hansen G, Dano K (1994) Studies on functional and structural role of urokinase receptor and other components of the plasminogen activation system in malignancy. Ann Biol Clin 52:775–782
26.
go back to reference Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, Nicolson GL, Ohshima K, Rao JS (1994) Activities, localizations, and roles of serine proteases and their inhibitors in human brain tumor progression. J Neurooncol 22:139–151CrossRefPubMed Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, Nicolson GL, Ohshima K, Rao JS (1994) Activities, localizations, and roles of serine proteases and their inhibitors in human brain tumor progression. J Neurooncol 22:139–151CrossRefPubMed
27.
go back to reference Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oka K, Rao VH, Tomonaga M, Nicolson GL, Rao JS (1994) Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res 54:3656–3661PubMed Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oka K, Rao VH, Tomonaga M, Nicolson GL, Rao JS (1994) Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res 54:3656–3661PubMed
28.
go back to reference Yokoyama S, Hirano H, Moroki K, Goto M, Imamura S, Kuratsu J-I (2001) Are nonfunctioning adenomas extending into the cavernous sinus aggressive and/or invasive? Neurosurgery 49:857–863 Yokoyama S, Hirano H, Moroki K, Goto M, Imamura S, Kuratsu J-I (2001) Are nonfunctioning adenomas extending into the cavernous sinus aggressive and/or invasive? Neurosurgery 49:857–863
29.
go back to reference Xu YC, Hagede J, Doublet JD, Callard P, Sraer JD, Ronne E, Rondeau E (1997) Endothelial and macrophage upregulation of urokinase receptor in human renal cell carcinoma. Hum Pathol 2:206–213 Xu YC, Hagede J, Doublet JD, Callard P, Sraer JD, Ronne E, Rondeau E (1997) Endothelial and macrophage upregulation of urokinase receptor in human renal cell carcinoma. Hum Pathol 2:206–213
Metadata
Title
Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue
Authors
Ulrich J. Knappe
Christian Hagel
Björn W. Lisboa
Waldemar Wilczak
Dieter K. Lüdecke
Wolfgang Saeger
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 5/2003
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-003-0747-5

Other articles of this Issue 5/2003

Acta Neuropathologica 5/2003 Go to the issue